Top 10 Healthcare Market Research Firms in Japan

 Japan’s healthcare market is one of the largest and most complex globally. With an aging population, a multi-payer insurance system, and unique regulatory frameworks, accessing accurate and timely market intelligence is crucial for pharmaceutical companies, medtech manufacturers, payers, and investors. Choosing the right healthcare market research partner in Japan can directly influence launch strategies, product positioning, portfolio decisions, and M&A activity. This article highlights the top 10 healthcare market research firms in Japan, evaluated for data depth, analytic capability, therapeutic expertise, and strategic impact.

How We Selected These Firms

Our selection criteria focused on:

1. Access to Japan-specific clinical, claims, and commercial data
   
   

2. Analytic and modeling capabilities, including real-world evidence (RWE) and forecasting
   
   

3. Track record in advising pharmaceutical, medtech, and investment clients in Japan
   
   

4. Local expertise, regulatory knowledge, and language capabilities
   
   

5. Delivery models encompassing consultancy, platform solutions, and custom research
   
   

1. IQVIA — Integrated Data and Analytics Leader

IQVIA is a global leader in healthcare data and analytics with extensive Japan-specific capabilities. Its integrated platforms combine claims, hospital records, prescription data, and clinical trial insights to deliver end-to-end intelligence. IQVIA’s real-world evidence and forecasting solutions support market entry, launch planning, and commercialization strategies, making it ideal for enterprise-scale needs.

2. M3 Global Research — Clinician Access and Fieldwork Expertise

M3 provides unparalleled access to Japanese healthcare professionals through its physician panel, covering hundreds of thousands of clinicians. Its primary research capabilities, including surveys, KOL interviews, and advisory panels, make it a top choice for market access studies, promotional strategy validation, and physician engagement programs in Japan.

3. JMDC — Claims and Payer Intelligence

JMDC specializes in claims and payer analytics, offering comprehensive longitudinal datasets covering health insurance claims, health checks, and treatment patterns. JMDC’s insights enable pharma and medtech teams to conduct epidemiology studies, budget-impact modeling, and HTA preparation within Japan’s complex multi-payer system.

4. DelveInsight — Therapy-Focused Research and Consulting

DelveInsight is a healthcare-focused market research firm providing deep insights across pharma and medtech therapy areas. Its Japan-specific reports include epidemiology, competitive intelligence, pipeline landscapes, and market access analyses. DelveInsight is particularly valuable for mid-sized biotechs and investors seeking therapy-level competitive intelligence and actionable guidance for local market strategies.

5. Medical Data Vision (MDV) — Hospital EHR and DPC Database Solutions

MDV operates one of Japan’s largest hospital-based electronic medical record databases. Its datasets support treatment pathway analysis, real-world evidence generation, post-marketing surveillance, and outcomes research. MDV is especially useful for companies needing granular hospital-level data for regulatory submissions and clinical insights.

6. Clarivate — Strategic Intelligence with Japan Focus

Clarivate, including Decision Resources Group (DRG), offers comprehensive life-science intelligence covering clinical, commercial, and payer datasets. Clarivate provides strategic insight for asset valuation, licensing, portfolio prioritization, and competitive landscaping, incorporating Japan-specific regulatory and reimbursement nuances.

7. Informa / Pharma Intelligence — Clinical and Regulatory Insights

Informa’s Pharma Intelligence portfolio delivers clinical trial tracking, regulatory monitoring, and congress-level reporting in Japan. Its offerings support trial-site intelligence, investigator networks, and timely updates on regulatory decisions, which are essential for clinical development planning and competitive benchmarking.

8. Frost & Sullivan — Growth Strategy and Market Opportunities

Frost & Sullivan combines market research with strategic consulting to identify growth opportunities. Its Japan-focused analyses cover medtech, digital health, and healthcare IT, providing actionable recommendations for market entry, commercialization, and expansion strategies. Frost’s insights help organizations translate market data into practical growth frameworks.

9. Kantar Health — Patient, Physician, and Market Insights

Kantar Health’s Japan capabilities include brand and product positioning research, patient journey mapping, and multi-stakeholder segmentation. Its expertise in capturing patient and HCP perspectives supports evidence-based decision-making for market access, product adoption, and communication strategies.

10. Nomura Research Institute (NRI) — Local Consulting and Analytics

NRI combines strategic consulting with healthcare analytics and IT integration. With deep knowledge of Japan’s policy environment, payer system, and regulatory landscape, NRI provides market modeling, scenario planning, and strategic guidance for investors and corporate teams seeking localized intelligence.

How to Choose the Right Provider

Selecting the right market research partner in Japan depends on the use case:

• Enterprise-scale intelligence: IQVIA and Clarivate provide comprehensive data integration and forecasting.
  
  

• Clinician-level insights: M3 and Kantar Health deliver rapid, validated primary research.
  
  

• Claims and hospital-level RWE: JMDC and MDV are indispensable for HTA, epidemiology, and post-market studies.
  
  

• Therapy-specific intelligence: DelveInsight excels in competitive analysis, market access, and pipeline evaluation.
  
  

• Strategic planning and growth execution: Frost & Sullivan and NRI provide actionable market insights and implementation frameworks.
  
  

Executives should define core objectives, assess methodological transparency, and consider combining providers to balance scale, local validity, and therapeutic depth. Integrating Japanese-language deliverables, regulatory expertise, and RWE capabilities ensures actionable insights that meet the country’s unique market and policy requirements.

Conclusion

Japan’s healthcare market demands specialized knowledge, local data, and culturally attuned insights. The top 10 market research firms listed here offer a blend of global scale, local expertise, and therapeutic focus, enabling companies to navigate regulatory complexities, optimize launches, and make evidence-based investment decisions. An effective intelligence strategy often combines multiple providers — pairing large-scale platforms with therapy-focused and locally embedded specialists like DelveInsight — to maximize insight accuracy, relevance, and impact in Japan’s dynamic healthcare environment.